These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33278160)

  • 1. Hidden in plain sight: sex and gender in global pandemics.
    Scully EP
    Curr Opin HIV AIDS; 2021 Jan; 16(1):48-53. PubMed ID: 33278160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interplay between HIV and COVID-19: summary of the data and responses to date.
    Brown LB; Spinelli MA; Gandhi M
    Curr Opin HIV AIDS; 2021 Jan; 16(1):63-73. PubMed ID: 33186229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first 6 months of HIV-SARS-CoV-2 coinfection: outcomes for 6947 individuals.
    Johnston R
    Curr Opin HIV AIDS; 2021 Jan; 16(1):54-62. PubMed ID: 33165007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2.
    Goraichuk IV; Arefiev V; Stegniy BT; Gerilovych AP
    Virus Res; 2021 Sep; 302():198473. PubMed ID: 34118360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics.
    Saleemi MA; Ahmad B; Benchoula K; Vohra MS; Mea HJ; Chong PP; Palanisamy NK; Wong EH
    Infect Genet Evol; 2020 Nov; 85():104583. PubMed ID: 33035643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The single-cell landscape of immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome coronavirus 2.
    Collora JA; Liu R; Albrecht K; Ho YC
    Curr Opin HIV AIDS; 2021 Jan; 16(1):36-47. PubMed ID: 33165008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology in the HIV and SARS-CoV-2 pandemics.
    Lorenzo-Redondo R; Ozer EA; Achenbach CJ; D'Aquila RT; Hultquist JF
    Curr Opin HIV AIDS; 2021 Jan; 16(1):11-24. PubMed ID: 33186230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV/SARS-CoV-2 coinfection: A global perspective.
    Kanwugu ON; Adadi P
    J Med Virol; 2021 Feb; 93(2):726-732. PubMed ID: 32692406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV and COVID-19: review of clinical course and outcomes.
    Barbera LK; Kamis KF; Rowan SE; Davis AJ; Shehata S; Carlson JJ; Johnson SC; Erlandson KM
    HIV Res Clin Pract; 2021 Aug; 22(4):102-118. PubMed ID: 34514963
    [No Abstract]   [Full Text] [Related]  

  • 12. A brief molecular insight of COVID-19: epidemiology, clinical manifestation, molecular mechanism, cellular tropism and immuno-pathogenesis.
    Singh S; Pandey R; Tomar S; Varshney R; Sharma D; Gangenahalli G
    Mol Cell Biochem; 2021 Nov; 476(11):3987-4002. PubMed ID: 34195882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intersecting Pandemics of HIV and SARS-CoV-2: Commentary on the Special Issue.
    Vermund SH
    Curr HIV/AIDS Rep; 2022 Feb; 19(1):1-4. PubMed ID: 35192108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2: a new dimension to our understanding of coronaviruses.
    Araf Y; Faruqui NA; Anwar S; Hosen MJ
    Int Microbiol; 2021 Jan; 24(1):19-24. PubMed ID: 33231780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Things must not fall apart: the ripple effects of the COVID-19 pandemic on children in sub-Saharan Africa.
    Coker M; Folayan MO; Michelow IC; Oladokun RE; Torbunde N; Sam-Agudu NA
    Pediatr Res; 2021 Apr; 89(5):1078-1086. PubMed ID: 32971527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality.
    Wehbe Z; Hammoud SH; Yassine HM; Fardoun M; El-Yazbi AF; Eid AH
    Front Immunol; 2021; 12():659339. PubMed ID: 34025658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-Related Factors in Cardiovascular Complications Associated to COVID-19.
    Megiorni F; Pontecorvi P; Gerini G; Anastasiadou E; Marchese C; Ceccarelli S
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immune response to COVID-19: Does sex matter?
    Ho JQ; Sepand MR; Bigdelou B; Shekarian T; Esfandyarpour R; Chauhan P; Serpooshan V; Beura LK; Hutter G; Zanganeh S
    Immunology; 2022 Aug; 166(4):429-443. PubMed ID: 35470422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of SARS-CoV-2 and COVID-19.
    Hu B; Guo H; Zhou P; Shi ZL
    Nat Rev Microbiol; 2021 Mar; 19(3):141-154. PubMed ID: 33024307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.